TENAPANOR |
TENAPANOR : Inhibitor of SLC9A3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SLC9A3 |
|
Inhibitor
0.1-10 mg/kg in rats.. Statistically significant effects can be seen at 0.1 mg/kg in some cases. The authors also note "dehydration was observed due to the exaggerated PD response (i.e., diarrhea) at the studied dose (30 mg/kg).
100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
The potency of Tenapanor was tested against NHE1, NHE2, NHE3, NaPiIIb, TGR5, ASBT, and Pit-1. Exclud ...
Potency Cellular
In Vitro
SLC9A3
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.2c00037
In Vivo Validations
Rat
Dose: 1-30 mg/Kg
Route of delivery:
Oral
Cmax:
<3 ng/mL
DOI Reference: 10.1021/acsmedchemlett.2c00037
Mouse
Chemical Information
| Molecular Formula | C50H66Cl4N8O10S2 |
| SMILEs | CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1 |
| InChI | InChI=1S/C50H66Cl4N8O10S2/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64)/t43-,44-/m0/s1 |
| Molecular weight | 1142.31 Da |
| AlogP | 6.156600000000009 |
| HBond acceptors | 18 |
| HBond donors | 6 |
| Atoms | 140 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.